A new study revealed that a laboratory-engineered virus known as rQT3 delayed the development of neuroblastoma and peripheral nerve sheath tumors without damaging healthy tissues and prolonged the life span of diseased mice. Researchers created the viral therapy by equipping the oncolytic herpes simplex virus with a gene that inhibits enzymes responsible for the growth of certain tumors.

Related Summaries